<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01029691</url>
  </required_header>
  <id_info>
    <org_study_id>F022873</org_study_id>
    <secondary_id>1K23HL095739-01</secondary_id>
    <nct_id>NCT01029691</nct_id>
  </id_info>
  <brief_title>Study of Positive Airway Pressure in Preeclampsia to Reduce Blood Pressure</brief_title>
  <official_title>Use of PAP in Women With Pre-eclampsia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to identify whether sleep-disordered breathing - as measured by
      overnight polysomnography - is associated with pre-eclampsia and to determine whether use of
      positive airway pressure can improve nocturnal blood pressure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Initial enrollment began with only women with a pre-existing diagnosis of pre-eclampsia. Part
      way through the study, IRB granted approval to expand recruitment to include other
      hypertensive diagnoses. So, in effect, a more accurate post hoc title would be Study of
      Positive Airway Pressure to Reduce Blood Pressure in Hypertensive Pregnancies.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Nocturnal Blood Pressure</measure>
    <time_frame>baseline and 1 week after PAP treatment.</time_frame>
    <description>measured by a 24 hour cuff, averaged across the night;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Worsening of Hypertension</measure>
    <time_frame>1-6 months after enrollment.</time_frame>
    <description>This outcome measure's purpose was to look at the impact of the APAP on blood pressure. This was done categorically by looking at worsening of hypertension with or without escalation of antihypertensive medications.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Severity of Sleep Disordered Breathing</measure>
    <time_frame>at baseline</time_frame>
    <description>Severity of sleep disordered breathing, using the apnea/hypopnea index (number of respiratory evens per hour of sleep), among participants who have or do not have nocturnal hypertension. Obstructive sleep apnea is typically considered present if the AHI is at least 5.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Sleep-disordered Breathing (SDB)</measure>
    <time_frame>Baseline night 1</time_frame>
    <description>Presence or absence of SDB (defined as an apnea/hypopnea index; AHI&gt;=5)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gestational Age at Delivery</measure>
    <time_frame>At delivery (within 6 months of enrollment).</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Birth Weight</measure>
    <time_frame>At delivery (within 6 months of enrollment)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NICU Admission</measure>
    <time_frame>at delivery (within 6 months of enrollment)</time_frame>
    <description>Number of mothers who had one (or more) babies admitted to NICU</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">125</enrollment>
  <condition>Preeclampsia</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Positive Airway Pressure (compliant)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm was women who used auto-titrating positive airway pressure (APAP) for at least 4 hours per night</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Positive Airway Pressure (non-compliant)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>No one was assigned to this arm, but for results data quality purposes, women assigned to PAP who were explicitly non-compliant (used less than 4 hours per night), were analyzed separately from women who were compliant with the PAP assignment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Positive Airway Pressure</intervention_name>
    <description>Women will use positive airway pressure until delivery</description>
    <arm_group_label>Positive Airway Pressure (compliant)</arm_group_label>
    <arm_group_label>Positive Airway Pressure (non-compliant)</arm_group_label>
    <other_name>PAP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women with preeclampsia who receive care at the University of Michigan Hospitals

          -  No current use of PAP therapy.

          -  Willing and able to provide informed consent.

        Exclusion Criteria:

          -  Current PAP therapy

          -  Any medical reason why PAP therapy may not be suitable (e.g., in patients with recent
             head trauma).

          -  Cognitively impaired and unable to understand informed consent.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Louise M O'Brien, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>O'Brien LM, Bullough AS, Chames MC, Shelgikar AV, Armitage R, Guilleminualt C, Sullivan CE, Johnson TR, Chervin RD. Hypertension, snoring, and obstructive sleep apnoea during pregnancy: a cohort study. BJOG. 2014 Dec;121(13):1685-93. doi: 10.1111/1471-0528.12885. Epub 2014 May 30.</citation>
    <PMID>24888772</PMID>
  </results_reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2009</study_first_submitted>
  <study_first_submitted_qc>December 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2009</study_first_posted>
  <results_first_submitted>August 9, 2017</results_first_submitted>
  <results_first_submitted_qc>September 14, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">October 16, 2017</results_first_posted>
  <last_update_submitted>September 14, 2017</last_update_submitted>
  <last_update_submitted_qc>September 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Louise O'Brien</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Sleep disordered breathing</keyword>
  <keyword>Preeclampsia</keyword>
  <keyword>Positive Airway Pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Pregnant women with hypertension were recruited from University of Michigan obstetric clinics and inpatient areas. Enrollment into the trial occurred between March 2010 and November 2013.</recruitment_details>
      <pre_assignment_details>After signing consent, one participant decided not to have any sleep studies performed, explaining the difference between the 125 enrolled listed in the registration section and the 124 followed below.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Compliant Users APAP</title>
          <description>Women who used APAP at least 4 hours per night. Auto-titrating Positive Airway Pressure: Women will use APAP until delivery. Nocturnal blood pressure will be assessed at two time points: 1 week of APAP use and at regular intervals across pregnancy. Daytime blood pressure measurements across pregnancy will be obtained from medical records along with delivery information.</description>
        </group>
        <group group_id="P2">
          <title>Non-Compliant APAP</title>
          <description>Women who were in the APAP arm but who used less than 4 hours per night</description>
        </group>
        <group group_id="P3">
          <title>Standard of Care</title>
          <description>Women in the standard of care group will have clinical blood pressure measurements extracted from medical records. Delivery information will also be collected.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>APAP Initiation to Week 1 or Delivery</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="27">4 delivered before APAP initiation 7 elected not to have APAP following baseline study</participants>
                <participants group_id="P3" count="77"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Baseline Sleep Study</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="23"/>
                <participants group_id="P3" count="77"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Began Actual APAP Use</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="16"/>
                <participants group_id="P3" count="77"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="16"/>
                <participants group_id="P3" count="77"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Continued APAP to Delivery</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="16"/>
                <participants group_id="P3" count="77"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="16"/>
                <participants group_id="P3" count="76"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>These data are for those who initiated APAP only and do not include the standard of care arm as they did not have nocturnal blood pressure</population>
      <group_list>
        <group group_id="B1">
          <title>Compliant Autotitrating Positive Airway Pressure (APAP)</title>
          <description>Women who used APAP for at least 4 hours/night</description>
        </group>
        <group group_id="B2">
          <title>Non-compliant APAP</title>
          <description>Women who did not use APAP for at least 4 hours/night</description>
        </group>
        <group group_id="B3">
          <title>Standard Care</title>
          <description>Non-APAP arm</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="16"/>
            <count group_id="B3" value="77"/>
            <count group_id="B4" value="113"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34.3" spread="4.8"/>
                    <measurement group_id="B2" value="32.3" spread="3.8"/>
                    <measurement group_id="B3" value="31.1" spread="6.6"/>
                    <measurement group_id="B4" value="31.8" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="77"/>
                    <measurement group_id="B4" value="113"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="52"/>
                    <measurement group_id="B4" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mixed Race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="77"/>
                    <measurement group_id="B4" value="113"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Nocturnal blood pressure</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Systolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="126.7" spread="9.5"/>
                    <measurement group_id="B2" value="124.5" spread="8.9"/>
                    <measurement group_id="B3" value="NA">Standard of care group did not have nocturnal blood pressure measures</measurement>
                    <measurement group_id="B4" value="125.8" spread="9.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.7" spread="8.0"/>
                    <measurement group_id="B2" value="68.8" spread="8.3"/>
                    <measurement group_id="B3" value="NA">Standard of care group did not have nocturnal blood pressure measures</measurement>
                    <measurement group_id="B4" value="69.3" spread="8.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>sleep study apnea hypopnea index (AHI)</title>
          <description>Number of respiratory events per hour of sleep</description>
          <units>events per hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18.9" spread="30.6"/>
                    <measurement group_id="B2" value="4.2" spread="6.0"/>
                    <measurement group_id="B3" value="NA">The standard of care arm did not undergo a sleep study</measurement>
                    <measurement group_id="B4" value="12.4" spread="24.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Nocturnal Blood Pressure</title>
        <description>measured by a 24 hour cuff, averaged across the night;</description>
        <time_frame>baseline and 1 week after PAP treatment.</time_frame>
        <population>The standard of care group did not have nocturnal blood pressure monitoring as they were not assigned to use a positive airway pressure device</population>
        <group_list>
          <group group_id="O1">
            <title>Positive Airway Pressure Adherent</title>
            <description>Positive Airway Pressure: Women will use positive airway pressure until delivery</description>
          </group>
          <group group_id="O2">
            <title>Positive Airway Pressure Non Adherent</title>
            <description>Positive Airway Pressure: Women who used positive airway pressure for limited time</description>
          </group>
          <group group_id="O3">
            <title>Standard Care</title>
          </group>
        </group_list>
        <measure>
          <title>Nocturnal Blood Pressure</title>
          <description>measured by a 24 hour cuff, averaged across the night;</description>
          <population>The standard of care group did not have nocturnal blood pressure monitoring as they were not assigned to use a positive airway pressure device</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline Nocturnal Systolic</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="16"/>
                    <count group_id="O3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="128.2" spread="9.8"/>
                    <measurement group_id="O2" value="124.7" spread="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline Nocturnal Diastolic</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="16"/>
                    <count group_id="O3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.6" spread="8.0"/>
                    <measurement group_id="O2" value="68.8" spread="8.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 week Systolic</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="127.7" spread="9.3"/>
                    <measurement group_id="O2" value="125.3" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 week Diastolic</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.9" spread="8.4"/>
                    <measurement group_id="O2" value="69.3" spread="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>unadjusted systolic blood pressure at baseline between groups</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.45</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Unadjusted diastolic blood pressure at baseline between groups</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.66</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Unadjusted systolic blood pressure at week 1</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.61</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Unadjusted diastolic blood pressure at week 1</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.75</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Worsening of Hypertension</title>
        <description>This outcome measure's purpose was to look at the impact of the APAP on blood pressure. This was done categorically by looking at worsening of hypertension with or without escalation of antihypertensive medications.</description>
        <time_frame>1-6 months after enrollment.</time_frame>
        <population>One woman in the standard of care group died during pregnancy and is therefore not included in this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Positive Airway Pressure Adherent</title>
            <description>Positive Airway Pressure: Women will use positive airway pressure until delivery</description>
          </group>
          <group group_id="O2">
            <title>Positive Airway Pressure Non Adherent</title>
            <description>Positive Airway Pressure: Women who used positive airway pressure for limited time</description>
          </group>
          <group group_id="O3">
            <title>Standard Care</title>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Worsening of Hypertension</title>
          <description>This outcome measure's purpose was to look at the impact of the APAP on blood pressure. This was done categorically by looking at worsening of hypertension with or without escalation of antihypertensive medications.</description>
          <population>One woman in the standard of care group died during pregnancy and is therefore not included in this analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="76"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.085</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Severity of Sleep Disordered Breathing</title>
        <description>Severity of sleep disordered breathing, using the apnea/hypopnea index (number of respiratory evens per hour of sleep), among participants who have or do not have nocturnal hypertension. Obstructive sleep apnea is typically considered present if the AHI is at least 5.</description>
        <time_frame>at baseline</time_frame>
        <population>This reflects only the n=43 women who underwent baseline sleep study (n=7 of whom did not go on to receive APAP therapy) prior to assignment to PAP therapy. The standard of care group did not have a baseline sleep study and are therefore not represented here. Of these n=43 women, n=36 received PAP therapy (n=20 were adherent and n=16 were not).</population>
        <group_list>
          <group group_id="O1">
            <title>Nocturnal Hypertension</title>
            <description>Women with nocturnal hypertension (defined as blood pressure &gt;117/68mmHg between 26-30 weeks and &gt;123/72mmHg after 30 weeks)</description>
          </group>
          <group group_id="O2">
            <title>No Nocturnal Hypertension</title>
            <description>Women without nocturnal hypertension</description>
          </group>
        </group_list>
        <measure>
          <title>Severity of Sleep Disordered Breathing</title>
          <description>Severity of sleep disordered breathing, using the apnea/hypopnea index (number of respiratory evens per hour of sleep), among participants who have or do not have nocturnal hypertension. Obstructive sleep apnea is typically considered present if the AHI is at least 5.</description>
          <population>This reflects only the n=43 women who underwent baseline sleep study (n=7 of whom did not go on to receive APAP therapy) prior to assignment to PAP therapy. The standard of care group did not have a baseline sleep study and are therefore not represented here. Of these n=43 women, n=36 received PAP therapy (n=20 were adherent and n=16 were not).</population>
          <units>apnea/hypopnea index</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.6" spread="25.9"/>
                    <measurement group_id="O2" value="2.7" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.012</p_value>
            <p_value_desc>Unadjusted</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Sleep-disordered Breathing (SDB)</title>
        <description>Presence or absence of SDB (defined as an apnea/hypopnea index; AHI&gt;=5)</description>
        <time_frame>Baseline night 1</time_frame>
        <population>This reflects only the n=43 women who underwent baseline sleep study (n=7 of whom did not go on to receive APAP therapy) prior to assignment to PAP therapy. The standard of care group did not have a baseline sleep study and are therefore not represented here. Of these n=43 women, n=36 received PAP therapy (n=20 were adherent and n=16 were not).</population>
        <group_list>
          <group group_id="O1">
            <title>Nocturnal Hypertension</title>
            <description>Women with nocturnal hypertension (defined as blood pressure &gt;117/68mmHg between 26-30 weeks and &gt;123/72mmHg after 30 weeks)</description>
          </group>
          <group group_id="O2">
            <title>No Nocturnal Hypertension</title>
            <description>Women without nocturnal hypertension</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Sleep-disordered Breathing (SDB)</title>
          <description>Presence or absence of SDB (defined as an apnea/hypopnea index; AHI&gt;=5)</description>
          <population>This reflects only the n=43 women who underwent baseline sleep study (n=7 of whom did not go on to receive APAP therapy) prior to assignment to PAP therapy. The standard of care group did not have a baseline sleep study and are therefore not represented here. Of these n=43 women, n=36 received PAP therapy (n=20 were adherent and n=16 were not).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Gestational Age at Delivery</title>
        <time_frame>At delivery (within 6 months of enrollment).</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Positive Airway Pressure Adherent</title>
            <description>Positive Airway Pressure: Women will use positive airway pressure until delivery</description>
          </group>
          <group group_id="O2">
            <title>Positive Airway Pressure Non Adherent</title>
            <description>Positive Airway Pressure: Women who used positive airway pressure for limited time</description>
          </group>
          <group group_id="O3">
            <title>Standard Care</title>
          </group>
        </group_list>
        <measure>
          <title>Gestational Age at Delivery</title>
          <units>weeks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.7" spread="3.7"/>
                    <measurement group_id="O2" value="36.0" spread="3.6"/>
                    <measurement group_id="O3" value="36.9" spread="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Birth Weight</title>
        <time_frame>At delivery (within 6 months of enrollment)</time_frame>
        <population>There is one extra baby in each arm to represent the twins born in each group.</population>
        <group_list>
          <group group_id="O1">
            <title>Positive Airway Pressure Adherent</title>
            <description>Positive Airway Pressure: Women will use positive airway pressure until delivery</description>
          </group>
          <group group_id="O2">
            <title>Positive Airway Pressure Non Adherent</title>
            <description>Positive Airway Pressure: Women who used positive airway pressure for limited time</description>
          </group>
          <group group_id="O3">
            <title>Standard Care</title>
          </group>
        </group_list>
        <measure>
          <title>Birth Weight</title>
          <population>There is one extra baby in each arm to represent the twins born in each group.</population>
          <units>grams</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>babies</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="75"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>babies</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="76"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2804.3" spread="1037.4"/>
                    <measurement group_id="O2" value="2749.7" spread="870.0"/>
                    <measurement group_id="O3" value="2957.5" spread="909.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>NICU Admission</title>
        <description>Number of mothers who had one (or more) babies admitted to NICU</description>
        <time_frame>at delivery (within 6 months of enrollment)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Positive Airway Pressure Adherent</title>
            <description>Positive Airway Pressure: Women will use positive airway pressure until delivery</description>
          </group>
          <group group_id="O2">
            <title>Positive Airway Pressure Non Adherent</title>
            <description>Positive Airway Pressure: Women who used positive airway pressure for limited time</description>
          </group>
          <group group_id="O3">
            <title>Standard Care</title>
          </group>
        </group_list>
        <measure>
          <title>NICU Admission</title>
          <description>Number of mothers who had one (or more) babies admitted to NICU</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>from start of intervention until 30 days after intervention (generally 30 days after delivery)</time_frame>
      <desc>NOTE: All cause mortality table reflects maternal death only - as babies were not participants.
Inpatient hospitalizations were not collected as data for adverse event collection (and therefore are not included in Serious Adverse Events reporting) because this was a study of high risk pregnancies, so recruitment came from inpatient candidates as well as from the community.
For non-serious adverse events: study did not collect ordinary aspects of pregnancy such as nausea.</desc>
      <group_list>
        <group group_id="E1">
          <title>Positive Airway Pressure</title>
          <description>Positive Airway Pressure: Women will use positive airway pressure until delivery</description>
        </group>
        <group group_id="E2">
          <title>Standard Care</title>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="77"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="77"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Neonatal death</sub_title>
                <description>pre-existing severe fetal growth restrictions involved in both cases; IRB approved determination that these are unrelated to study participation or intervention. Neonatal deaths not tracked in standard of care arm</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="77"/>
              </event>
              <event>
                <sub_title>medical abortion</sub_title>
                <description>severe growth restriction of fetus with no interval growth on serial ultrasounds as well as oligohydramnios</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="77"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="77"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>These tables represent full basic analysis of all the participants enrolled without adjustment for confounding variables. Future publications will present more complex subsequent analyses.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Louise O'Brien</name_or_title>
      <organization>University of Michigan</organization>
      <phone>734 647-9064</phone>
      <email>louiseo@med.umich.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

